Breaks Categories: Stock Spotlights

WednesdayJan 25, 2017 10:02 am

NetworkNewsBreaks – Mobivity Holdings Corp. (MFON) Establishes Notable Growth in 2016, Starts New Year with New Deal

Mobivity Holdings (OTCQB: MFON) develops and operates proprietary platforms that help brands and enterprises conduct national and localized, data-driven mobile marketing campaigns. By revolutionizing the way companies use their data to predict and influence customer behavior to accelerate their business, Mobivity is a leader in the Cognitive Transaction Data Platform Category. The company was recently chosen by Dutch Bros Coffee to provide its SmartMessenger enterprise mobile marketing solution to help the coffee chain manage its 275+ locations. Mobivity Holdings in November reported revenues for the first nine months of 2016 at $6.1 million, an increase of $2.8 million, or 83%,…

Continue Reading

WednesdayJan 25, 2017 9:58 am

NetworkNewsBreaks – ClearSign Combustion Corporation (CLIR) Achieves Low Levels of NOx Emissions with Duplex Burner

Companies are making substantial efforts to lower their emissions with Selective Catalytic Reduction (SCR) and Low NOx Burners (LNB). Because these solutions create both financial and operational challenges, ClearSign Combustion Corporation (NASDAQ: CLIR) has introduced its Duplex™ Technology. Duplex burner technology is designed to improve operations by offering a more balanced fuel-air blend to nearly eliminate the formation of nitrogen oxide and increase thermal capacity, while reducing operational and maintenance costs. Duplex™ can be applied to refinery process heaters, steam generation, and virtually any other system in which there is a flame. The company recently announced the completion and customer…

Continue Reading

TuesdayJan 24, 2017 9:46 am

NetworkNewsBreaks – WidePoint Corporation (NYSE: WYY) Forecasts Strong 2017 Performance on Key Corporate Variables

WidePoint Corporation (NYSE: WYY) provides managed mobility services, telecommunications lifecycle management, and cybersecurity solutions. Since its first merger in 1998, WidePoint has demonstrated a pattern of growth through strategic mergers with highly specialized regional IT consulting companies, most of which have been in business for decades. In November 2016, WidePoint posted third-quarter net revenue of approximately $22.1 million, an increase of 30% compared to $17.0 million in the third quarter of 2015. The company also cut its net loss to $148,000 in the third quarter of 2016 compared to a loss of $1.8 million in the year ago quarter. WidePoint was also operationally…

Continue Reading

TuesdayJan 24, 2017 9:39 am

NetworkNewsBreaks – Finjan Holdings, Inc. (NASDAQ: FNJN) Keeps Pace as Best Cybersecurity Patent Litigator

Finjan Holdings (NASDAQ: FNJN) provides intellectual property licensing and enforcement services, develops mobile security applications, provides consulting services, and invests in innovation. Over the last year, the company has built a reputation as cybersecurity's top patent litigator. In August of 2015 Finjan received a unanimous jury verdict and $39.5M in damages against Blue Coat that its patents were valid and mostly infringed. More recently, in September of 2016, Finjan received a jury verdict in its trial against Sophos confirming the validity and infringement of its patents and $15M in damages. The company has several pending infringement lawsuits against Blue Coat, as…

Continue Reading

TuesdayJan 24, 2017 9:33 am

NetworkNewsBreaks – Delcath Systems, Inc. (NASDAQ: DCTH) Investigating Novel Therapy for the Treatment of Certain Unresectable Liver Cancers

With an initial potential market opportunity in ocular melanoma liver metastases of between $104 million and $260 million at stake, Delcath Systems (NASDAQ: DCTH) is working with the U.S. FDA toward approval of the company’s Melphalan/Hepatic Delivery System (Melphalan/HDS) chemotherapy system for treatment of certain unresectable liver cancers. The Melphalan/HDS system facilitates the delivery of melphalan directly to the liver and, consequently, allows the administration of higher doses. The blood is then filtered to reduce the level of melphalan and returned to the patient, thereby potentially reducing hematologic side effects. In 2016, Delcath initiated its global FOCUS phase 3 trial in hepatic dominant ocular…

Continue Reading

MondayJan 23, 2017 1:00 pm

NetworkNewsBreaks – AmeriCann, Inc. (ACAN) Building One of the Nation’s Largest MMJ Facilities

AmeriCann (OTCQX: ACAN), a medical marijuana facility developer based in Denver, Colorado, recently launched the first phase of its planned MMJ facility in Massachusetts, and retained highly-experienced Campanelli Construction as general contractor.  In the first quarter of 2017, AmeriCann plans to break ground on the Massachusetts Medical Cannabis Center – which is approved for 1 million square feet – and expects to have its preferred partners start cannabis production on the property by fall. When complete, the facility will be one of the largest and most technologically-advanced medical marijuana centers in the United States. The first phase of the project…

Continue Reading

MondayJan 23, 2017 12:57 pm

NetworkNewsBreaks – RMG Networks Holding Corp. (NASDAQ: RMGN) Innovations Meet Demand for Digital Signage Messaging

For over 35 years, RMG Networks Holding (NASDAQ: RMGN) has been going beyond traditional communications to help businesses increase productivity, efficiency and engagement through digital signage messaging. Today, many companies are turning toward digital signage solutions to easily display their visual data on multiple devices for a variety of initiatives. When it comes to corporate communications, for example, RMG delivers real-time internal communications directly to employee desktops and mobile devices, enabling 100% reach, optimal impact, and a unique way to boost employee engagement and productivity. With a strong portfolio of hardware and software design, RMG in less than three years…

Continue Reading

MondayJan 23, 2017 12:52 pm

NetworkNewsBreaks – Resonant, Inc. (NASDAQ: RESN) Aims to Change Mobile Industry with Proprietary RF Filter Design

The mobile industry is still using radio frequency filters designed based on technology that has hardly changed over the past century and therefore is not able to fully meet the industry’s new challenges and requirements. Resonant, Inc. (NASDAQ: RESN), a developer of software tools and designs for radio frequency front-ends (RFFE) filters, is looking to change that via its proprietary Infinite Synthesized Networks™ technology. ISN™ has the potential of answering one of the industry’s biggest challenges: being able to tune or reconfigure RF filters to work across several bands simultaneously. Resonant is working on developing innovative single-band and tunable designs…

Continue Reading

MondayJan 23, 2017 12:49 pm

NetworkNewsBreaks – Digital Ally, Inc. (NASDAQ: DGLY) Capitalizing on the Increased Use of Mobile Devices

With the rampant application and use of mobile technologies, Digital Ally, Inc. (NASDAQ: DGLY) has designed a complete evidence management solution for law enforcement and security agencies, accessible through a mobile application called VuVault Go™. The app gives law enforcement officers full control of evidence, as well as the ability to take notes and playback videos. As a result, agencies have control over digital evidence while on the job. CJIS-compliant, VuVault Go™ offers secure access to recordings on both Android and iOS devices. The mobile application is part of the company’s VuVault® platform, which also includes VuVault.Com™, a secure Internet-based…

Continue Reading

FridayJan 20, 2017 12:34 pm

NetworkNewsBreaks – Second Sight Medical Products, Inc. (NASDAQ: EYES) Sees Mounting Potential for Argus® II “Bionic Eye” Implants

Second Sight Medical Products (NASDAQ: EYES) develops, manufactures and markets implantable prosthetic devices to restore functional vision to blind patients. The company’s Argus II System is an implantable neurostimulation device that uses electrical stimulation of the retina to replace the function of the defunct photo-receptors in retinitis pigmentosa patients. Second Sight wrapped up 2016 with an announcement that for the first time in the UK, the publicly-funded NHS system would fund blind patients with retinitis pigmentosa (RP) to receive treatment with Second Sight’s innovative Argus® II Retinal Prosthesis System (Argus II) “bionic eye.” The company most recently announced a rights…

Continue Reading